Lot Kimia

Lyphochek® Assayed Chemistry Control
Levels 1 and 2
C-310-5 Level 1 12 x 5 mL Level 1 26451
C-315-5 Level 2 12 x 5 mL 0459 2021-05-31 26450 Level 2 26452
313X MiniPak 2 x 5 mL
http://www.myeinserts.com/26450
METODE (1)
Level 1 - 26451 Level 2 - 26452
Unit Rata-rata Rentang Rata-rata Rentang
ACETAMINOPHEN
Emit 2000 (3) µg/mL 16.5 11.9 – 21.0 86.0 75.4 – 96.7
ACID PHOSPHATASE (TOTAL)
Accurex Biomedical (a-naphthyl phosphate) U/L § §
ALBUMIN
Agappe Diagnostics Ltd. (Biolis 24i) (4) g/dL 4.50 3.70 – 5.30 3.50 2.70 – 4.40
Agappe Diagnostics Ltd. (MISPA NANO) (4) g/dL 4.20 3.50 – 4.80 3.40 2.60 – 4.20
Agappe Diagnostics Ltd. (Toshiba TBA-120FR) (4) g/dL 4.10 3.53 – 4.67 3.20 2.50 – 3.80
Bromcresol green (3) g/dL 4.11 3.64 – 4.58 2.72 2.38 – 3.06
Catechem ChemWell-T (Bromcresol green) (4) g/dL 4.40 3.30 – 5.50 3.10 2.50 – 3.70
Fortress Diagnostics (Bromcresol green) (BXC0222) (4) g/dL 4.05 3.45 – 4.66 2.80 2.38 – 3.21
Sekisui Medical Clinimate, Autosera (Dye Binding-BCG) (4) g/dL 4.00 3.70 – 4.30 2.70 2.40 – 3.00
Teco Diagnostics TC-Matrix (Bromcresol green) g/dL § §
ALKALINE PHOSPHATASE (2)
Agappe Diagnostics Ltd. (Biolis 24i) (4) U/L 174 119 – 229 556 439 – 672
Agappe Diagnostics Ltd. (MISPA NANO) (4) U/L 141 88.2 – 195 463 366 – 561
Agappe Diagnostics Ltd. (Toshiba TBA-120FR) (4) U/L 174 126 – 222 553 449 – 657
Catachem ChemWell-T (4) U/L 108 79.0 – 137 453 378 – 528
Fortress Diagnostics (AMP) (BXC0184) U/L § §
Fortress Diagnostics (DEA) (BXC0185) (4) U/L 235 199 – 270 691 587 – 794
PNPP, AMP Buffer (3) U/L 113 83.9 – 141 456 382 – 529
Sekisui Medical Pureauto S, Autosera S, Qualigent ALP (4) U/L 302 277 – 327 1018 948 – 1088
Teco Diagnostics TC-Matrix (Modified Bowers-McComb Liquid) U/L § §
ALT/SGPT (2)
Agappe Diagnostics Ltd. (Biolis 24i) (4) U/L 25.9 16.9 – 34.9 98.7 77.5 – 120
Agappe Diagnostics Ltd. (MISPA NANO) (4) U/L 32.7 24.1 – 41.4 102 82.7 – 121
Agappe Diagnostics Ltd. (Toshiba TBA-120FR) (4) U/L 26.7 20.2 – 33.2 97.9 84.1 – 112
Catachem ChemWell-T (4) U/L 30.0 21.0 – 39.0 103 80.0 – 126
Fortress Diagnostics (IFCC UV Liquid) (BXCO213) (4) U/L 28.1 23.9 – 32.4 104 88.6 – 120
IFCC 2002 (UV with P5P) (3) U/L 28.6 22.4 – 34.8 96.5 82.4 – 111
IFCC 2002 (UV without P5P) (3) U/L 26.7 20.3 – 33.0 92.2 79.4 – 105
Sekisui Medical Pureauto S, Qualigent (ALT-L) (UV without P5P) (4) U/L 27.0 22.0 – 32.0 93.0 81.0 – 105
Teco Diagnostics TC-Matrix (Optimized Tris Liquid) U/L § §
AMYLASE (2)
Accurex Biomedical (Gal G2 a-CNP) (4) U/L 79.3 55.1 – 104 520 438 – 602
Agappe Diagnostics Ltd. (Biolis 24i) (4) U/L 64.7 50.8 – 78.6 441 388 – 495
Halaman 1 BAHASA INDONESIA/Indonesian • 2018-10 • 4030-00
8
Lyphochek® Assayed Chemistry Control, Levels 1 and 2
METODE (1)
Level 1 - 26451 Level 2 - 26452
AMYLASE (2) (terus menerus)
Agappe Diagnostics Ltd. (MISPA NANO) (4) U/L 61.6 49.0 – 74.1 429 376 – 481
Agappe Diagnostics Ltd. (Toshiba TBA-120FR) (4) U/L 63.8 54.3 – 73.4 435 380 – 491
Catachem ChemWell-T (4) U/L 76.0 52.0 – 100 473 360 – 586
EPS-G7 (3) U/L 80.9 70.3 – 91.6 388 355 – 421
Fortress Diagnostics (CNPG3) (BXC0562) (4) U/L 109 92.4 – 125 434 369 – 499
Fortress Diagnostics (EPS) (BXC0563) (4) U/L 59.4 50.5 – 68.3 381 324 – 438
Sekisui Medical Pureauto S, Qualigent AMY-G2 (4) U/L 91.0 86.0 – 96.0 561 541 – 581
Teco Diagnostics TC-Matrix U/L § §
Teco Diagnostics TC-Matrix (Kinetic) U/L § §
AMYLASE (PANCREATIC) (2)
EPS-G7 Liquid (3) U/L 48.4 37.4 – 59.3 360 332 – 388
Sekisui Medical Pureauto S, Qualigent P-AMY-G2 (4) U/L 63.0 58.0 – 68.0 536 511 – 561
AST/SGOT (2)
Catachem ChemWell-T (4) U/L 34.0 23.0 – 45.0 176 126 – 226
Fortress Diagnostics (IFCC UV Liquid) (BXCO203) (4) U/L 42.3 35.9 – 48.6 231 196 – 265
IFCC 2002 (UV with P5P) (3) U/L 42.2 34.4 – 49.9 227 200 – 255
IFCC 2002 (UV without P5P) (3) U/L 39.3 31.8 – 46.9 207 181 – 233
Sekisui Medical Pureauto S, Qualigent AST-L (UV without P5P) (4) U/L 42.0 37.0 – 47.0 223 211 – 235
Teco Diagnostics TC-Matrix (Optimized Tris Liquid) U/L § §
BILIRUBIN (DIRECT)
Advanced Instruments BR2 Bilirubin Stat-Analyzer (Photometric) (4) mg/dL 0.120 0.000 – 0.200 0.750 0.400 – 1.10
Agappe Diagnostics Ltd. (Biolis 24i) (4) mg/dL 0.213 0.067 – 0.360 0.759 0.498 – 1.02
Agappe Diagnostics Ltd. (MISPA NANO) (4) mg/dL 0.255 0.089 – 0.421 0.765 0.505 – 1.03
Agappe Diagnostics Ltd. (Toshiba TBA-120FR) (4) mg/dL 0.200 0.073 – 0.332 0.700 0.500 – 0.900
Catachem ChemWell-T (4) mg/dL 0.300 0.170 – 0.430 0.970 0.710 – 1.22
Diazotization / DPD / Jendrassik Grof (3) mg/dL 0.201 0.061 – 0.341 0.785 0.539 – 1.03
Fortress Diagnostics (Jendrassik Grof) (BXC0191) (4) mg/dL 0.297 0.253 – 0.342 0.581 0.494 – 0.668
Teco Diagnostics TC-Matrix (Diazotization) mg/dL § §
Vanadate Oxidation (3) mg/dL 0.306 0.220 – 0.392 1.21 0.945 – 1.48
Wako L-Type (AU480) (4) mg/dL 0.346 0.317 – 0.375 1.22 0.963 – 1.48
BILIRUBIN (TOTAL)
Accurex Biomedical (Jendrassik Grof, DMSO) (4) mg/dL 0.960 0.690 – 1.23 4.20 3.47 – 4.93
Advanced Instruments BR2 Bilirubin Stat-Analyzer (Photometric) (4) mg/dL 1.89 1.50 – 2.30 4.45 3.60 – 5.30
DPD (3) mg/dL 1.04 0.712 – 1.36 4.43 3.66 – 5.21
Fortress Diagnostics (Jendrassik Grof) (BXC0192) (4) mg/dL 1.27 1.08 – 1.46 4.05 3.44 – 4.66
Jendrassik Grof (3) mg/dL 1.01 0.707 – 1.31 4.39 3.80 – 4.98
Teco Diagnostics TC-Matrix (Sulphanilic acid, DMSO) mg/dL § §
Vanadate Oxidation (3) mg/dL 1.05 0.867 – 1.23 4.58 4.04 – 5.12
8
METODE (1)
Level 1 - 26451 Level 2 - 26452
BILIRUBIN (TOTAL) (terus menerus)
CALCIUM
Accurex Biomedical (Arsenazo III) (4) mg/dL 9.52 8.13 – 10.9 12.3 11.0 – 13.6
Accurex Biomedical (o-cresolphthalein complexone) (4) mg/dL 9.06 7.34 – 10.8 12.4 11.0 – 13.8
Arsenazo III (3) mg/dL 9.78 8.71 – 10.8 12.1 10.9 – 13.3
Fortress Diagnostics (Arsenazo III) (BXC0292) (4) mg/dL 10.1 8.56 – 11.6 12.3 10.4 – 14.2
Fortress Diagnostics (OCPC) (BXC0291) (4) mg/dL 9.08 7.72 – 10.4 12.4 10.6 – 14.3
o-cresolphthalein complexone (3) mg/dL 9.35 8.50 – 10.2 12.2 11.2 – 13.3
Sekisui Medical Clinimate, Qualigent CA (4) mg/dL 8.90 8.00 – 9.80 11.9 10.7 – 13.1
Teco Diagnostics TC-Matrix (Arsenazo III) mg/dL § §
Teco Diagnostics TC-Matrix (o-cresolphthalein complexone) mg/dL § §
CALCIUM (IONIZED)
ISE Direct mg/dL § §
CARBAMAZEPINE
Emit 2000 (3) µg/mL 3.16 2.49 – 3.83 16.6 13.7 – 19.5
CARBON DIOXIDE (CO2)
Teco Diagnostics TC-Matrix (Enzymatic) mEq/L § §
CHLORIDE
Accurex Biomedical (Mercuric Thiocyanate) (4) mEq/L 95.0 84.4 – 106 83.9 76.2 – 91.6
Agappe Diagnostics Ltd. (Biolis 24i) (4) mEq/L 93.2 80.8 – 106 84.8 70.6 – 99.1
Agappe Diagnostics Ltd. (MISPA NANO) (4) mEq/L 96.8 84.5 – 109 90.9 76.1 – 106
Agappe Diagnostics Ltd. (Toshiba TBA-120FR) (4) mEq/L 99.4 95.0 – 104 90.9 80.9 – 101
Agappe Diagnostics Ltd. (Toshiba TBA-25FR) mEq/L § §
Fortress Diagnostics (Thiocyanate) (BXC0281) (4) mEq/L 102 87.1 – 118 89.8 76.3 – 103
ISE Indirect (3) mEq/L 106 98.5 – 114 87.1 81.6 – 92.6
Sekisui Medical Internal Standard Solution -K/-B, Dilutent -K/-B (4) mEq/L 101 94.0 – 108 83.0 78.0 – 88.0
Teco Diagnostics TC-Matrix (Mercuric Thiocyanate) mEq/L § §
CHOLESTEROL (HDL) (7)
Accurex Biomedical (Direct Homogenous-Autopure) (4) mg/dL 82.3 65.7 – 98.9 29.9 19.6 – 40.2
Direct measure (3) mg/dL 72.4 56.5 – 88.2 27.1 18.7 – 35.5
Fortress Diagnostics (Direct) (BXC0421) (4) mg/dL 86.9 73.7 – 100 32.4 27.4 – 37.1
Sekisui Medical Cholestest N, Qualigent N HDL (4) mg/dL 76.8 67.8 – 85.8 28.9 24.9 – 32.9
CHOLESTEROL (LDL)
Accurex Biomedical (Direct Homogenous-Autopure) (4) mg/dL 146 117 – 175 56.7 38.5 – 74.9
Agappe Diagnostics Ltd. (Biolis 24i) (4) mg/dL 156 132 – 180 72.3 57.6 – 87.1
Agappe Diagnostics Ltd. (MISPA NANO) (4) mg/dL 143 123 – 163 62.6 50.3 – 74.9
Agappe Diagnostics Ltd. (Toshiba TBA-120FR) (4) mg/dL 154 138 – 170 67.4 56.2 – 78.5
Direct measure (3) mg/dL 143 117 – 169 62.1 49.1 – 75.1
8
METODE (1)
Level 1 - 26451 Level 2 - 26452
CHOLESTEROL (LDL) (terus menerus)
Fortress Diagnostics (Direct) (BXC0431) (4) mg/dL 122 104 – 140 53.7 45.6 – 61.8
Sekisui Medical Cholestest, Qualigent LDL (4) mg/dL 134 125 – 143 59.5 54.5 – 64.5
Wako L-Type (AU480) (4) mg/dL 144 140 – 148 68.8 66.9 – 70.7
CHOLESTEROL (TOTAL)
Accurex Biomedical (Cholesterol oxidase-Peroxidase) (4) mg/dL 245 208 – 282 105 87.0 – 123
Agappe Diagnostics Ltd. (Biolis 24i) (4) mg/dL 283 239 – 328 119 92.8 – 144
Agappe Diagnostics Ltd. (MISPA NANO) (4) mg/dL 252 214 – 290 98.2 80.6 – 116
Agappe Diagnostics Ltd. (Toshiba TBA-120FR) (4) mg/dL 264 228 – 300 104 86.7 – 122
Agappe Diagnostics Ltd. (Toshiba TBA-25FR) (4) mg/dL 273 224 – 323 111 74.2 – 148
CHOD-PAP (3) mg/dL 251 227 – 276 98.3 85.9 – 111
Fortress Diagnostics (CHOD-PAP Liquid) (BXC0261) (4) mg/dL 262 223 – 301 108 91.5 – 124
Sekisui Medical Cholestest, Qualigent CHO (4) mg/dL 254 242 – 266 107 97.0 – 117
Sekisui Medical Pureauto S CHO-N (4) mg/dL 255 243 – 267 106 96.0 – 116
Teco Diagnostics TC-Matrix (Enzymatic Liquid) mg/dL § §
CHOLINESTERASE (2)
Accurex Biomedical (Butyrylthiocholine) (4) U/L 6862 6049 – 7675 4517 3874 – 5160
Butyrylthiocholine (3) U/L 7797 6577 – 9017 5053 4014 – 6092
Fortress Diagnostics (Butyrylthiocholine DGKC) (BXC0801) (4) U/L 7608 6467 – 8750 4825 4101 – 5548
COMPLEMENT C3
Sekisui Medical (Immunotesta C3) (4) mg/dL 119 107 – 131 83.0 78.0 – 88.0
COPPER
Atomic Absorption µg/dL 106 77.4 – 135 67.5 47.8 – 87.3
Fortress Diagnostics (Colorimetric, End Point) (BXC0341) (4) µg/dL 125 106 – 144 70.4 59.8 – 81.0
CREATINE KINASE (CK) (2)
Accurex Biomedical (NAC activated) (4) U/L 130 92.0 – 168 402 325 – 479
Agappe Diagnostics Ltd. (MISPA NANO) (4) U/L 127 97.8 – 157 453 391 – 516
Catachem ChemWell-T (4) U/L 151 117 – 185 450 349 – 551
Fortress Diagnostics (NAC Activated Liquid) (BXCO252) (4) U/L 154 131 – 177 497 422 – 572
IFCC 2002 (3) U/L 141 117 – 164 449 398 – 500
Sekisui Medical Pureauto S CK (4) U/L 140 120 – 160 456 426 – 486
Sekisui Medical Pureauto S, Qualigent CK-L (4) U/L 133 113 – 153 439 409 – 469
Teco Diagnostics TC-Matrix (UV Kinetic) U/L § §
CREATININE
Accurex Biomedical (Jaffe, Kinetic) (4) mg/dL 2.14 1.55 – 2.73 5.24 4.27 – 6.21
Agappe Diagnostics Ltd. (Biolis 24i - Enzymatic) (4) mg/dL 1.90 1.20 – 2.50 5.50 4.50 – 6.60
Agappe Diagnostics Ltd. (Biolis 24i - Jaffe) (4) mg/dL 2.30 1.60 – 3.10 4.90 3.50 – 6.20
Agappe Diagnostics Ltd. (MISPA NANO - Enzymatic) (4) mg/dL 1.70 1.20 – 2.20 5.40 4.60 – 6.20
Agappe Diagnostics Ltd. (MISPA NANO - Jaffe) (4) mg/dL 2.10 1.60 – 2.50 4.80 3.60 – 5.90
Agappe Diagnostics Ltd. (Toshiba TBA-120FR - Enzymatic) (4) mg/dL 1.90 1.59 – 2.30 5.60 4.60 – 6.60
Agappe Diagnostics Ltd. (Toshiba TBA-120FR - Jaffe) (4) mg/dL 2.20 1.58 – 2.79 4.90 3.90 – 5.80
Agappe Diagnostics Ltd. (Toshiba TBA-25FR - Enzymatic) (4) mg/dL 1.95 1.20 – 2.70 5.70 4.80 – 6.60
Agappe Diagnostics Ltd. (Toshiba TBA-25FR - Jaffe) (4) mg/dL 2.26 1.60 – 2.90 4.90 3.70 – 6.10
Alkaline picrate-kinetic (3) mg/dL 2.28 1.82 – 2.73 5.45 4.74 – 6.15
Enzymatic (3) mg/dL 1.91 1.37 – 2.45 5.17 4.45 – 5.88
Fortress Diagnostics (Enzymatic) (BXC0113) (4) mg/dL 1.99 1.69 – 2.29 5.15 4.38 – 5.92
8
METODE (1)
Level 1 - 26451 Level 2 - 26452
CREATININE (terus menerus)
Fortress Diagnostics (Jaffe) (BXC0111) (4) mg/dL 2.39 2.03 – 2.75 5.33 4.53 – 6.13
Sekisui Medical Clinimate CRE (4) mg/dL 2.50 2.20 – 2.80 5.60 5.00 – 6.20
Sekisui Medical Pureauto S CRE-L (4) mg/dL 1.80 1.60 – 2.00 5.00 4.80 – 5.30
Sekisui Medical Pureauto S, Qualigent CRE-N (4) mg/dL 1.90 1.70 – 2.10 5.20 5.00 – 5.50
Teco Diagnostics TC-Matrix (Jaffe Kinetic) mg/dL § §
DIGOXIN
Emit 2000 (3) ng/mL 1.19 0.758 – 1.63 3.38 2.54 – 4.22
GAMMA GLUTAMYLTRANSFERASE (GGT) (2)
Accurex Biomedical (IFCC) (4) U/L 63.8 49.0 – 78.6 140 117 – 163
Agappe Diagnostics Ltd. (MISPA NANO) (4) U/L 53.4 43.0 – 63.9 149 130 – 167
Fortress Diagnostics (Glycylglycine Liquid) (BXC0362) (4) U/L 55.9 47.5 – 64.3 142 121 – 164
IFCC 2002 (3) U/L 60.0 47.2 – 72.8 157 127 – 188
Sekisui Medical Pureauto S GGT (4) U/L 60.0 55.0 – 65.0 159 144 – 174
Sekisui Medical Pureauto S, Qualigent y-GT (4) U/L 62.0 57.0 – 67.0 166 151 – 181
Teco Diagnostics TC-Matrix (Kinetic Liquid) U/L § §
GENTAMICIN
Emit 2000 (3) µg/mL 1.68 1.15 – 2.20 6.73 5.81 – 7.64
GLUCOSE
Accurex Biomedical (Glucose oxidase-Peroxidase) (4) mg/dL 91.2 72.9 – 110 280 251 – 309
Agappe Diagnostics Ltd. (Biolis 24i) (4) mg/dL 93.9 77.1 – 111 279 247 – 311
Agappe Diagnostics Ltd. (MISPA NANO) (4) mg/dL 82.9 69.6 – 96.2 285 251 – 319
Agappe Diagnostics Ltd. (Toshiba TBA-120FR) (4) mg/dL 86.0 76.6 – 95.4 274 244 – 305
Agappe Diagnostics Ltd. (Toshiba TBA-25FR) (4) mg/dL 92.6 77.5 – 108 282 245 – 318
Dr. Mueller Geraetebau GmbH, SUPER G1, SUPER G2, SUPER GL Serie (4) mg/dL 84.7 75.3 – 94.1 281 250 – 312
EKF und Eppendorf (BIOSEN-, EBIO basic -und EBIO compact -Analysatoren)
GOD (4) mg/dL 83.8 74.6 – 93.2 274 244 – 304
Fortress Diagnostics (GOD-PAP) (BXC0101) (4) mg/dL 84.0 71.4 – 96.6 273 232 – 314
Fortress Diagnostics (Hexokinase) (BXC0103) (4) mg/dL 103 87.2 – 118 285 242 – 328
GOD-POD (3) mg/dL 87.5 72.9 – 102 268 236 – 301
Hexokinase (3) mg/dL 82.4 72.2 – 92.6 282 257 – 306
Kabe Labortechnik GmbH (GA 2/3 mit Dickschichtelectrode-DSE) (4) mg/dL 87.1 77.5 – 96.5 278 248 – 308
Sekisui Medical Pureauto S GLU (4) mg/dL 81.0 75.0 – 87.0 272 257 – 287
Sekisui Medical Pureauto S, Qualigent GLU-R (4) mg/dL 81.0 75.0 – 87.0 273 258 – 288
Teco Diagnostics TC-Matrix (Glucose Oxidase Liquid) mg/dL § §
Teco Diagnostics TC-Matrix (Hexokinase Liquid) mg/dL § §
GLUTAMATE DEHYDROGENASE (GLDH) (2) (3)
DiaSys U/L 7.20 5.61 – 8.78 14.1 12.7 – 15.5
Standard Method without Correction for the Non-Specific Creep Reaction U/L 6.84 5.43 – 8.24 13.8 12.3 – 15.2
HAPTOGLOBIN
Immunoturbidimetric (3) mg/dL 115 100 – 129 81.1 70.2 – 91.9
IMMUNOGLOBULIN A (IGA)
Immunoturbidimetric (3) mg/dL 186 158 – 213 131 107 – 155
Sekisui Medical Pureauto S IgA (4) mg/dL 188 173 – 203 135 125 – 145
IMMUNOGLOBULIN G (IGG)
8
METODE (1)
Level 1 - 26451 Level 2 - 26452
IMMUNOGLOBULIN G (IGG) (terus menerus)
Sekisui Medical Pureauto S IgG (4) mg/dL 956 906 – 1006 686 656 – 716
IMMUNOGLOBULIN M (IGM)
Immunoturbidimetric (3) mg/dL 81.8 63.7 – 99.9 54.2 38.5 – 69.9
Sekisui Medical Pureauto S IgM (4) mg/dL 89.0 79.0 – 99.0 62.0 57.0 – 67.0
IRON
Ferrozine (3) µg/dL 243 223 – 263 64.9 54.8 – 75.0
Fortress Diagnostics (Ferene) (BXC0232) (4) µg/dL 231 196 – 265 60.8 51.7 – 69.9
Fortress Diagnostics (Ferrozine) (BXC0235) (4) µg/dL 254 216 – 292 77.9 66.2 – 89.6
Teco Diagnostics TC-Matrix (Ferrozine) µg/dL § §
IRON (TIBC)
Fortress Diagnostics (BXC0237) (4) µg/dL 275 234 – 316 217 184 – 249
IRON (UIBC)
Sekisui Medical Pureauto S UIBC (4) µg/dL 94.0 79.0 – 109 153 138 – 168
LACTATE (LACTIC ACID)
Dr. Mueller Geraetebau GmbH, SUPER G1, SUPER G2, SUPER GL Serie (4) mg/dL 36.8 32.8 – 40.9 11.8 10.5 – 13.1
EKF und Eppendorf (BIOSENS-, EBIObasic-und EBIOcompact-Analysatoren) LOD
(4) mg/dL 35.9 31.9 – 39.7 9.82 8.74 – 10.9
Enzymatic (3) mg/dL 28.6 25.3 – 31.9 7.10 5.07 – 9.12
Fortress Diagnostics (Enzymatic, colorimetric) (BXC0622) (4) mg/dL 36.0 30.6 – 41.4 7.57 6.49 – 8.74
LACTATE DEHYDROGENASE (LDH) (2)
Accurex Biomedical (P-L, UV Kinetic) (4) U/L 360 293 – 427 797 699 – 895
Agappe Diagnostics Ltd. (MISPA NANO) (4) U/L 343 280 – 407 807 708 – 906
Fortress Diagnostics (L-P) (BXC0243) (4) U/L 172 146 – 197 316 269 – 363
Fortress Diagnostics (P-L) (BXC0242) (4) U/L 328 279 – 377 763 720 – 850
IFCC 2002 (3) U/L 178 161 – 195 364 337 – 391
Sekisui Medical Pureauto S LD, Qualigent LD (4) U/L 174 164 – 184 369 349 – 389
Sekisui Medical Pureauto S LD-P (4) U/L 403 383 – 423 915 865 – 965
Teco Diagnostics TC-Matrix (Modified Wacker Tris, Kinetic) (Liquid) U/L § §
LAP ARYLAMIDASE (2)
Sekisui Medical Pureauto LAP (4) U/L 47.0 41.0 – 53.0 33.0 30.0 – 36.0
LIPASE (2)
Accurex Biomedical (Colorimetric) (4) U/L 49.0 39.5 – 58.8 65.3 46.0 – 84.6
Agappe Diagnostics Ltd. (Biolis 24i) U/L § §
Agappe Diagnostics Ltd. (Toshiba TBA-120FR) (4) U/L 52.0 46.4 – 57.6 71.3 60.0 – 82.7
Agappe Diagnostics Ltd. (Toshiba TBA-25FR) (4) U/L 41.1 35.6 – 46.7 55.2 39.8 – 70.6
ANALYTICON/Biocon: Fluitest Lipase (Colorimetric) (4) U/L 44.9 38.2 – 51.6 66.5 56.5 – 76.5
Colorimetric (3) U/L 196 163 – 229 296 251 – 341
Enzymatic, colorimetric (3) U/L 44.1 35.7 – 52.6 71.7 59.3 – 84.2
Fortress Diagnostics (BXC0511) (4) U/L 29.3 24.9 – 33.7 57.5 48.9 – 66.1
LITHIUM
Atomic Absorption mEq/L § §
Flame Photometry mEq/L 0.628 0.521 – 0.735 1.81 1.51 – 2.10
MAGNESIUM
Accurex Biomedical (Xylidyl blue) (4) mg/dL 2.30 1.74 – 2.86 4.25 3.32 – 5.18
8
METODE (1)
Level 1 - 26451 Level 2 - 26452
MAGNESIUM (terus menerus)
Atomic Absorption mg/dL 2.01 1.65 – 2.38 4.21 3.27 – 5.14
Fortress Diagnostics (Xylidyl blue) (BXC0352) (4) mg/dL 2.43 2.07 – 2.80 4.40 3.74 – 5.06
Sekisui Medical Clinimate MG (4) mg/dL 2.00 1.70 – 2.30 4.40 4.00 – 4.80
Teco Diagnostics TC-Matrix (Calmagite) mg/dL § §
Teco Diagnostics TC-Matrix (Xylidyl blue) mg/dL § §
Xylidyl blue (3) mg/dL 2.17 1.75 – 2.59 4.54 3.91 – 5.17
OSMOLALITY
Freezing Point Depression mOSM/kg 566 537 – 596 472 448 – 496
PHENOBARBITAL
Emit 2000 (3) µg/mL 13.2 7.03 – 19.3 46.6 34.0 – 59.2
PHENYTOIN
Emit 2000 (3) µg/mL 9.39 6.31 – 12.5 24.8 17.1 – 32.6
PHOSPHORUS
Accurex Biomedical (Ammonium Molybdate, UV Endpoint) (4) mg/dL 3.74 3.07 – 4.41 7.23 6.21 – 8.25
Fortress Diagnostics (UV Molybdate) (BXC0301) (4) mg/dL 3.93 3.34 – 4.52 7.46 6.35 – 8.58
Phosphomolybdate-UV (3) mg/dL 3.51 3.08 – 3.94 7.28 6.64 – 7.92
Sekisui Medical Clinimate IP-2 (4) mg/dL 3.40 3.10 – 3.70 7.20 6.20 – 8.20
Teco Diagnostics TC-Matrix (Molybdenum UV) mg/dL § §
POTASSIUM
Flame Photometry mEq/L § §
Fortress Diagnostics (Colorimetric) (BXC0138) (4) mEq/L 4.07 3.46 – 4.68 6.69 5.69 – 7.70
ISE Indirect (3) mEq/L 3.93 3.69 – 4.17 6.17 5.83 – 6.51
Sekisui Medical Internal Standard Solution -K/-B, Dilutent -K/-B (4) mEq/L 4.00 3.80 – 4.20 6.20 5.70 – 6.70
Teco Diagnostics TC-Matrix (Turbidimetric) mEq/L § §
PROTEIN SERUM (TOTAL)
Accurex Biomedical (Biuret) (4) g/dL 6.44 5.59 – 7.29 4.36 3.66 – 5.06
Agappe Diagnostics Ltd. (Biolis 24i) (4) g/dL 6.40 5.70 – 7.10 4.40 3.50 – 5.40
Agappe Diagnostics Ltd. (MISPA NANO) (4) g/dL 6.30 5.70 – 6.90 4.30 3.40 – 5.20
Biuret, no serum blank, end point (3) g/dL 6.52 5.89 – 7.15 4.30 3.83 – 4.78
Biuret, serum blank, end point (3) g/dL 6.56 6.04 – 7.09 4.37 3.96 – 4.77
Fortress Diagnostics (Biuret) (BXC0173) (4) g/dL 6.17 5.25 – 7.10 4.10 3.48 – 4.71
Sekisui Medical Clinimate, Autosera, Qualigent TP (4) g/dL 6.30 5.90 – 6.70 4.20 3.80 – 4.60
Teco Diagnostics TC-Matrix (Biuret) g/dL § §
SALICYLATE
Emit (3) mg/dL 7.45 5.78 – 9.12 16.9 15.2 – 18.5
SODIUM
Fortress Diagnostics (BXC0142) mEq/L § §
ISE Indirect (3) mEq/L 144 137 – 150 123 117 – 128
8
METODE (1)
Level 1 - 26451 Level 2 - 26452
SODIUM (terus menerus)
Sekisui Medical Internal Standard Solution -K/-B, Dilutent -K/-B (4) mEq/L 146 136 – 156 125 115 – 135
THEOPHYLLINE
Emit 2000 (3) µg/mL 8.55 6.91 – 10.2 24.7 21.7 – 27.7
TOBRAMYCIN
Emit 2000 (3) µg/mL 7.53 6.24 – 8.83 1.66 0.958 – 2.37
TRANSFERRIN
TRIGLYCERIDES
Accurex Biomedical (GPO-POD) (4) mg/dL 198 151 – 245 93.4 72.4 – 114
Agappe Diagnostics Ltd. (Biolis 24i) (4) mg/dL 206 178 – 234 86.5 73.1 – 100
Agappe Diagnostics Ltd. (MISPA NANO) (4) mg/dL 182 158 – 207 78.2 66.2 – 90.2
Enzymatic / GPO (3) mg/dL 196 173 – 220 96.3 79.9 – 113
Fortress Diagnostics (GPO-PAP) (BXC0271) (4) mg/dL 191 163 – 219 94.7 80.5 – 109
Sekisui Medical Cholestest, Qualigent TG (4) mg/dL 195 183 – 207 91.8 82.8 – 101
Sekisui Medical Pureauto S, Autosera S TG-N (4) mg/dL 193 178 – 208 89.4 80.4 – 98.4
Teco Diagnostics TC-Matrix (Enzymatic GPO Liquid) mg/dL § §
UREA (5)
Accurex Biomedical (Modified Berthelot) (4) mg/dL 33.6 25.4 – 41.8 97.8 83.2 – 112
Urease (3) mg/dL 33.6 28.8 – 38.4 101 90.7 – 111
UREA NITROGEN (BUN) (5)
Accurex Biomedical (Urease, GLDH) (4) mg/dL 16.6 12.3 – 20.9 45.5 36.0 – 55.0
Fortress Diagnostics (BXC0123) (4) mg/dL 16.0 13.6 – 18.4 49.0 41.6 – 56.3
Sekisui Medical Pureauto S UN (4) mg/dL 15.5 13.0 – 18.0 46.9 41.9 – 51.9
Sekisui Medical Pureauto S, Qualigent UN-L (4) mg/dL 14.7 11.7 – 17.7 44.9 39.9 – 49.9
Teco Diagnostics TC-Matrix (Urease, GLDH Liquid) mg/dL § §
Urease (3) mg/dL 15.7 13.4 – 17.9 47.0 42.2 – 51.8
URIC ACID
Accurex Biomedical (Uricase) (4) mg/dL 5.71 4.82 – 6.60 10.6 9.00 – 12.2
AUTOPAK (Enzymatic) mg/dL § §
Fortress Diagnostics (Uricase PAP Monoliquid) (BXC0603) (4) mg/dL 4.87 4.14 – 5.60 10.1 8.58 – 11.6
Sekisui Medical Pureauto S, Autosera S, Qualigent UA (4) mg/dL 4.80 4.50 – 5.10 10.1 9.40 – 10.8
Teco Diagnostics TC-Matrix (Uricase Liquid) mg/dL § §
Uricase, colorimetric (3) mg/dL 4.71 4.08 – 5.35 9.92 8.96 – 10.9
Uricase, UV (3) mg/dL 4.65 4.14 – 5.16 9.86 8.98 – 10.7
VALPROIC ACID
Emit 2000 (3) µg/mL 45.3 28.8 – 61.7 142 106 – >150
VANCOMYCIN
Emit 2000 (3) µg/mL 6.89 5.45 – 8.33 27.8 23.5 – 32.1
8
METODE (1)
Level 1 - 26451 Level 2 - 26452
ZINC
Atomic Absorption µg/dL 125 92.5 – 157 75.7 43.2 – 108
Fortress Diagnostics (BXC0462) (4) µg/dL 166 141 – 191 134 114 – 154
8
INSTRUMEN
Level 1 - 26451 Level 2 - 26452
SIEMENS DIMENSION SERIES
Acetaminophen (Enzymatic, colorimetric) µg/mL 20.3 15.5 – 25.1 95.6 87.1 – 104
Albumin (Bromcresol Purple (BCP)) g/dL 3.90 3.59 – 4.21 2.59 2.37 – 2.81
Alkaline Phosphatase (IFCC ALPI) (2) U/L 107 67.8 – 146 430 280 – 580
ALT/SGPT (IFCC ALTI) (2) U/L 34.7 27.3 – 42.2 102 85.5 – 119
Amylase (CNP-triose/CNPG3) (2) U/L 77.3 70.3 – 84.3 493 453 – 533
AST/SGOT (2) U/L 43.4 34.9 – 51.8 225 201 – 248
AST/SGOT (IFCC 2002 Correlated) (2) U/L 43.5 35.1 – 51.9 225 201 – 249
Bilirubin (Direct) (Diazotization) (DBI) mg/dL 0.200 0.098 – 0.303 0.797 0.628 – 0.967
Bilirubin (Total) (Jendrassik Grof) (TBI) mg/dL 0.960 0.765 – 1.16 4.33 3.87 – 4.78
Calcium mg/dL 9.25 8.34 – 10.2 12.2 11.1 – 13.2
Carbamazepine µg/mL 2.89 2.21 – 3.57 15.5 12.8 – 18.2
Carbon Dioxide (CO2) (Enzymatic) mEq/L 35.4 28.9 – 42.0 18.2 13.4 – 23.0
Chloride (EXL/Xpand) mEq/L 120 108 – 133 96.3 85.7 – 107
Chloride (RxL) mEq/L 119 106 – 133 95.0 83.6 – 106
Cholesterol (HDL) (DF48B) (7) mg/dL 62.4 47.8 – 77.0 24.6 19.1 – 30.0
Cholesterol (LDL) (ALDL) mg/dL 140 120 – 160 60.1 50.1 – 70.2
Cholesterol (Total) mg/dL 252 227 – 276 91.5 79.1 – 104
Cholinesterase (Butyrylthiocholine (Trinder)) (2) U/L 12638 12033 – 13243 8659 8054 – 9264
Creatine Kinase (CK) (IFCC CKI) (2) U/L 141 122 – 161 436 392 – 480
Creatinine (CRE2) mg/dL 2.72 2.33 – 3.11 6.06 5.32 – 6.81
Creatinine (EZCR) mg/dL 2.07 1.28 – 2.86 5.27 4.47 – 6.07
Digoxin (EIA) ng/mL 0.551 0.280 – 0.822 2.20 1.84 – 2.55
Gamma Glutamyltransferase (GGT) (2) U/L 75.6 63.3 – 88.0 189 165 – 214
Gamma Glutamyltransferase (GGT) (IFCC 2002 Correlated) (2) U/L 64.7 52.8 – 76.7 163 139 – 187
Gentamicin (Immunoturbidimetric) µg/mL 1.72 1.21 – 2.23 6.75 5.73 – 7.78
Glucose (Hexokinase) mg/dL 92.8 84.1 – 101 282 258 – 306
Immunoglobulin A (IgA) mg/dL 169 142 – 195 121 96.8 – 145
Immunoglobulin G (IgG) mg/dL 914 755 – 1073 610 471 – 749
Immunoglobulin M (IgM) mg/dL 66.3 50.8 – 81.8 47.0 32.1 – 61.9
Iron (Ferene) µg/dL 240 222 – 259 63.5 54.3 – 72.7
Iron (TIBC) (IBCT) µg/dL 331 280 – 382 208 167 – 248
Lactate (Lactic Acid) (Enzymatic) mg/dL 36.2 30.2 – 42.2 8.97 5.30 – 12.6
Lactate Dehydrogenase (LDH) (IFCC LDI) (2) U/L 171 135 – 207 372 306 – 437
Lipase (Colorimetric) (2) U/L 184 153 – 214 266 227 – 305
Lithium (Colorimetric) mEq/L 0.709 0.580 – 0.838 2.02 1.69 – 2.35
Magnesium mg/dL 2.21 1.89 – 2.53 4.63 4.16 – 5.10
Phenobarbital µg/mL 15.7 9.59 – 21.9 49.7 39.3 – 60.0
Phenytoin µg/mL 10.7 8.16 – 13.2 26.2 21.7 – 30.8
Phosphorus (DF61A) mg/dL 3.74 3.36 – 4.12 7.55 6.98 – 8.12
Potassium (EXL/Xpand) mEq/L 3.89 3.63 – 4.16 6.21 5.80 – 6.62
Potassium (RxL) mEq/L § §
Protein Serum (Total) g/dL 6.83 6.32 – 7.34 4.54 4.15 – 4.93
Salicylate (Trinder) mg/dL 7.74 6.50 – 8.99 11.3 9.70 – 12.8
Sodium (EXL/Xpand) mEq/L 144 136 – 151 123 117 – 130
Sodium (RxL) mEq/L § §
T3 Uptake/T Uptake (EIA) % Uptake 38.4 20.9 – 56.0 54.6 45.1 – 64.0
T4 (Free) ng/dL 0.837 0.690 – 0.983 >6.50
T4 (Free) (Chemiluminescence) ng/dL 0.952 0.870 – 1.03 >8.00
8
INSTRUMEN
Level 1 - 26451 Level 2 - 26452
SIEMENS DIMENSION SERIES (terus menerus)
T4 (Total) (EIA) µg/dL 8.10 5.85 – 10.3 22.4 17.0 – >24.0
Theophylline µg/mL 8.45 6.78 – 10.1 23.2 17.7 – 28.7
Thyroid Stimulating Hormone (TSH) (Chemiluminescence) µIU/mL 1.44 1.27 – 1.61 17.1 15.7 – 18.5
Thyroid Stimulating Hormone (TSH) (EIA) µIU/mL 1.02 0.611 – 1.43 13.2 10.0 – 16.4
Tobramycin µg/mL 7.77 6.13 – 9.40 1.64 1.08 – 2.21
Transferrin mg/dL 218 186 – 249 164 143 – 184
Triglycerides (Enzymatic, end point) mg/dL 191 173 – 210 92.6 80.4 – 105
Urea Nitrogen (BUN) (Urease, UV) (5) mg/dL 15.5 12.6 – 18.4 47.2 39.2 – 55.3
Uric Acid (Uricase, UV) mg/dL 4.63 4.17 – 5.10 9.79 9.01 – 10.6
Valproic Acid µg/mL 42.0 34.8 – 49.3 125 102 – 149
Vancomycin µg/mL 7.06 5.45 – 8.66 31.6 27.2 – 36.0
CATATAN KAKI
(1) Semua catatan kaki bisa jadi tidak berlaku pada grafik data pilihan Anda.
(2) Nilai-nilai diperoleh pada suhu 37°C.
(3) Nilai rata-rata dihitung dari data yang dihasilkan oleh instrumen-instrumen yang menggunakan metode ini.
(4) Nilai yang ditetapkan tersebut ditentukan menggunakan protokol dari pabrik pembuat reagensia dan/atau instrumen dan tidak menggambarkan kisaran ±3SD.
(5) mg/dL urea nitrogen x 2,14 = mg/dL Urea. Rentang nilai Unit S.I. dinyatakan sebagai Urea.
(6) Produk ini telah diuji dengan menggunakan metodologi yang tercantum dalam brosur kemasan. Kinerja produk ini belum dievaluasi untuk digunakan dengan
metode elektroforesis kapiler.
(7) Hanya metode langsung.
(8) % Protein Total
Data tidak tersedia pada saat ini. Harap tanyakan.
§ Data yang dibutuhkan untuk menentukan nilai rata-rata dan rentang nilai keberterimaan pada pengujian uji ini tidak diperoleh karena peserta yang terbatas.
Jika laboratorium Anda berminat untuk berperan serta dalam Program Penetapan Nilai untuk pengujian ini, silahkan menghubungi kantor Bio-Rad setempat.

Lot Kimia

Transféré par

Informations du document

Titre original

Copyright

Formats disponibles

Partager ce document

Partager ou intégrer le document

Options de partage

Avez-vous trouvé ce document utile ?

Ce contenu est-il inapproprié ?

Droits d'auteur :

Formats disponibles

Lot Kimia

Transféré par

Droits d'auteur :

Formats disponibles

Lyphochek® Assayed Chemistry Control

Halaman 1 BAHASA INDONESIA/Indonesian • 2018-10 • 4030-00

Halaman 2 BAHASA INDONESIA/Indonesian • 2018-10 • 4030-00

Halaman 3 BAHASA INDONESIA/Indonesian • 2018-10 • 4030-00

Halaman 4 BAHASA INDONESIA/Indonesian • 2018-10 • 4030-00

Halaman 5 BAHASA INDONESIA/Indonesian • 2018-10 • 4030-00

Halaman 6 BAHASA INDONESIA/Indonesian • 2018-10 • 4030-00

Halaman 7 BAHASA INDONESIA/Indonesian • 2018-10 • 4030-00

Halaman 8 BAHASA INDONESIA/Indonesian • 2018-10 • 4030-00

Halaman 9 BAHASA INDONESIA/Indonesian • 2018-10 • 4030-00

Halaman 10 BAHASA INDONESIA/Indonesian • 2018-10 • 4030-00

Halaman 11 BAHASA INDONESIA/Indonesian • 2018-10 • 4030-00

Vous aimerez peut-être aussi